Did The Scotts Miracle-Gro Company Insiders Breach their Fiduciary Duties to Shareholders?
05-06-2026 21:48 via prnewswire.com

Did The Scotts Miracle-Gro Company Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. NEW...
Read more »

PR Public relations news



MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP
MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP
In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care
In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care
PureHealth Research Highlights Growing Consumer Interest in Lymphatic Wellness and Botanical Support
PureHealth Research Highlights Growing Consumer Interest in Lymphatic Wellness and Botanical Support
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - STLA
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - STLA
Clinical Amino Acid Profiles Anchor PureHealth Research's New Natural Peptides Supplements
Clinical Amino Acid Profiles Anchor PureHealth Research's New Natural Peptides Supplements
Quantinuum annonce la clôture de son premier appel public à l'épargne élargi
Quantinuum annonce la clôture de son premier appel public à l'épargne élargi
Lifeline AI gewinnt das Red Bull Basement World Final, bei dem 100.000 US-Dollar als Finanzierung ohne Abgabe von Unternehmensanteilen vergeben werden
Lifeline AI gewinnt das Red Bull Basement World Final, bei dem 100.000 US-Dollar als Finanzierung ohne Abgabe von Unternehmensanteilen vergeben werden
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
AVAV INVESTOR NOTICE: AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
AVAV INVESTOR NOTICE: AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Quantinum anuncia el cierre de su oferta pública inicial ampliada
Quantinum anuncia el cierre de su oferta pública inicial ampliada
Quantinuum gibt Abschluss des erweiterten Börsengangs bekannt
Quantinuum gibt Abschluss des erweiterten Börsengangs bekannt
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
Desktop versie